Edition:
United Kingdom

Ems Chemie Holding AG (EMSN.S)

EMSN.S on Swiss Exchange

632.50CHF
23 May 2018
Change (% chg)

CHF-11.50 (-1.79%)
Prev Close
CHF644.00
Open
CHF643.00
Day's High
CHF644.00
Day's Low
CHF632.50
Volume
15,730
Avg. Vol
23,435
52-wk High
CHF712.50
52-wk Low
CHF581.00

Chart for

About

EMS-CHEMIE HOLDING AG is a Switzerland-based holding company and producer and supplier of polymers and chemicals. The Company operates in two business segments: High Performance Polymers and Specialty Chemicals. The High Performance Polymers business segment comprises EMS-GRIVORY, a manufacturer of high-performance polyamides... (more)

Overall

Beta: 1.02
Market Cap(Mil.): CHF14,816.95
Shares Outstanding(Mil.): 23.39
Dividend: 13.00
Yield (%): 2.68

Financials

  EMSN.S Industry Sector
P/E (TTM): 32.15 18.71 356.26
EPS (TTM): 19.70 -- --
ROI: 26.44 18.43 10.65
ROE: 29.52 25.76 13.82

BRIEF-EMS Chemie FY Net Income Up 6.3 Pct At CHF 484 Million

* SAID ON THURSDAY FY NET SALES GREW BY 8.2% TO REACH CHF 2,146 MILLION

09 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs - sources

LONDON/FRANKFURT Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion (£1.7 billion), sources familiar with the matter told Reuters.

05 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs: sources

LONDON/FRANKFURT Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.

05 Feb 2018

Brazil's EMS and India's Torrent Pharma vying for Sanofi's generic drugs -sources

LONDON/FRANKFURT, Feb 5 Brazilian drugs firm EMS and Indian rival Torrent Pharma have emerged as the only industry bidders for Sanofi's generic drugs unit, battling a series of buyout funds for an asset worth as much as $2.4 billion, sources familiar with the matter told Reuters.

05 Feb 2018

Earnings vs. Estimates